• SCHEDULE OVERVIEW
• GENERAL SESSION SCHEDULE
• PRE-COURSE SCHEDULES
• NON-PHYSICIAN TRACK SCHEDULE
• ABSTRACT SCHEDULE

• SCHEDULE OVERVIEW

  Annual Meeting Breakout Schedule

  ---

  ---

  • Continuing Education Credits
  • Goals/Objectives and Expected Results

  ---

  Posted: 
  PDF version

  SUNDAY, JUNE 1
  7:00 AM	4:00 PM	Registration
  8:00 AM	5:00 PM	PRE-COURSE: Diving
  8:00 AM	5:00 PM	PRE-COURSE: Safety: Evaluating equipment for safe use in the hyperbaric environment
  12:00 PM	1:00 PM	Lunch (on own)
  6:30 PM	8:30 PM	Welcome Reception with AsMA
  MONDAY, JUNE 2
  7:00 AM	4:00 PM	Registration
  8:00 AM	8:45 AM	Opening Ceremony / Welcome Announcements / Keynote Introductions with AsMA
  8:45 AM	10:00 AM	Bauer Lecture with AsMA
  10:00 AM	10:30 AM	AsMA-UHMS Exhibits / Break
  10:30 AM	11:45 AM	UHMS Kindwall Keynote with AsMA: Shai Efrati, MD:  The Development of Hyperbaric Medicine from Decompression to Regeneration
  12:00 PM	2:00 PM	Lunch (on own)
  Session A - HBO2 Theory and Mechanisms
  2:00 PM	2:30 PM	Plenary: International Panel
  2:30 PM	2:40 PM	oral abstract	Posters: A B C
  2:40 PM	2:50 PM	oral abstract
  2:50 PM	3:00 PM	oral abstract
  3:00 PM	3:30 PM	Plenary: Session A
  3:30 PM	4:00 PM	AsMA-UHMS Exhibits / Break
  Session B - Clinical HBO2
  4:00 PM	4:30 PM	Plenary: Session B
  4:30 PM	4:40 PM	oral abstract	Posters A B C
  4:40 PM	4:50 PM	oral abstract
  4:50 PM	5:00 PM	oral abstract
  5:20 AM	5:30 PM	Plenary: UHM Fellows: Top articles in Hyperbaric Medicine
  TUESDAY, JUNE 3
  8:00 AM	4:00 PM	Registration
  8:30 AM	9:00 AM	Announcements / Keynote Introductions with AsMA
  9:00 AM	10:00 AM	Reinartz Lecture with AsMA
  10:00 AM	10:30 AM	AsMA-UHMS Exhibits / Break
  10:30 AM	11:45 AM	UHMS Lambertsen Keynote with AsMA:
  12:00 PM	2:00 PM	Lunch (on own)
  Session C - Decompression Theory and Mechanisms
  2:00 PM	2:30 PM	Plenary: Session C
  2:30 PM	2:40 PM	oral abstract	Posters D E F
  2:40 PM	2:50 PM	oral abstract
  2:50 PM	3:00 PM	oral abstract
  3:00 PM	3:30 PM	Plenary:  UHMS STEM Opportunity: Virginie Papadopoulou, PhD
  3:30 PM	4:00 PM	AsMA-UHMS Exhibits / Break
  Session D - Diving Medicine
  4:00 PM	4:30 PM	Plenary: Session D
  4:30 PM	4:40 PM	oral abstract
  4:40 PM	4:50 PM	oral abstract
  4:50 PM	5:00 PM	oral abstract
  5:00 PM	5:30 PM	Plenary: UHM Fellows: Top articles in Undersea Medicine
  WEDNESDAY, JUNE 4
  8:00 AM	4:00 PM	Registration
  8:30 AM	10:00 AM	Plenary
  10:00 AM	10:30 AM	AsMA-UHMS Exhibits / Break
  Session E - HBO2 Operations, Chambers and Equipment
  10:30 AM	11:00 AM	Plenary: Session E
  11:00 AM	11:10 AM	oral abstract
  11:10 AM	11:20 AM	oral abstract
  11:20 AM	11:30 AM	oral abstract
  11:30 AM	12:00 PM	Plenary / orals
  12:00 PM	2:00 PM	Lunch (on own)
  Session F - Top Case Reports
  2:00 PM	2:30 PM	Plenary: Session F
  2:30 PM	2:40 PM	oral abstract
  2:40 PM	2:50 PM	oral abstract
  2:50 PM	3:00 PM	oral abstract
  3:00 PM	3:30 PM	Plenary / orals
  3:30 PM	4:00 PM	AsMA-UHMS Exhibits / Break
  4:00 PM	5:30 PM	RAM Bowl with AsMA
  7:00 PM	10:00 PM	UHMS honors night
  THURSDAY, JUNE 5
  8:00 AM	2:00 PM	Registration
  7:30 AM	8:00 AM	UHMS Business Meeting
  8:00 AM	8:15 AM	Announcements / Keynote Introductions with AsMA
  8:15 AM	9:15 AM	Armstrong Lecture with AsMA
  9:15 AM	9:45 AM	Break
  9:45 AM	11:15 AM	Hart Keynote (Michael Strauss, MD)
  11:30 PM	1:30 PM	Lunch (on own)
  ASSOCIATES BREAKOUT SESSION
  1:30 PM	2:00 PM
  2:00 PM	2:30 PM
  2:30 PM	3:00 PM
  3:00 PM	3:30 PM	break
  3:30 PM	4:00 PM
  4:00 PM	4:30 PM
  4:30 PM	5:00 PM
  6:00 PM	9:00 PM	AsMA honors night
  9:00 PM	12:00 PM	AsMA / UHMS after party

   

  Read more

• GENERAL SESSION SCHEDULE

  THURSDAY, JUNE 18 - SATURDAY, JUNE 20
  PDF copy
  Subject to change
  Posted 
  

   

  COMING SOON 

   

  
  

   

   

   

  Read more

• PRE-COURSE SCHEDULES

  PRE-COURSES: WEDNESDAY, JUNE 17
  

        
  FITNESS TO DIVE

  subject to change: posted: 

  ---

  Read more

• NON-PHYSICIAN TRACK SCHEDULE

  SATURDAY, JUNE 20
  Posted: 
  (not approved for physician CME credits)
  

  COMING SOON 

   

   

  Read more

• ABSTRACT SCHEDULE

  ABSTRACT SCHEDULE

  ---

  POSTED: 4/10/23

  ---

  FRIDAY, JUNE 16
  11:30 AM	12:00 PM	Posters: Session A: (A1-A2, A4) & Session B: (B5, B7-B21)
  		A1: Hippocampal neuronal death partially inhibited with early hyperbaric oxygen therapy in asphyxial cardiac arrest rat model: Hyoung Youn Lee, PhD
  		A2: Oxidative burst and cytokine expression in patients and healthy volunteers receiving hyperbaric oxygen: A pilot study: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
  		A4: Early single-session hyperbaric oxygen therapy attenuates post cardiac arrest renal injury in asphyxial cardiac arrest rat model: YS Lee, MD
  		B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD
  		B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay C. Buckey, M.D.
  		B8: Pilot evaluation of long-term follow-up for the Multicenter Registry for Hyperbaric Oxygen Therapy: Jay C. Buckey, M.D.
  		B9: Multicenter Hyperbaric Outcomes Registry: 2022 review: Jay C. Buckey M.D.
  		B10: Retrospective assessment of the “Duke Mods”, An approach to reducing hyperbaric tender decompression sickness risk for multiplace chamber operations: M. Claire Ellis
  		B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning: Yong Sung Cha, MD, PhD
  		B12: Utility of echocardiographic global longitudinal strain to predict myocardial fibrosis in patients in carbon monoxide poisoning: Yong Sung Cha, MD, PhD
  		B13: Hyperbaric oxygen therapy regimens, treated conditions, and adverse effect profile: A UHMS survey study: Matteo Laspro, BA
  		B14: Perception and availability of hyperbaric oxygen therapy as a treatment modality for carbon monoxide poisoning among emergency medicine physicians: Tyler Connely, BS
  		B15: Early hyperbaric oxygen therapy is associated with favorable outcome in iatrogenic cerebral arterial gas embolism: Individual patient data meta-analysis of observational studies: Robert P. Weenink, CAPT (Navy), MD, PhD
  		B16: Hyperbaric oxygen therapy chamber supervision across the usa: how often do practitioners supervise more than one HBO2 simultaneously?: Helen Gelly, MD, FUHM, UHM/ABPM
  		B17: Inflammatory response profiles in COVID-19 patients treated with hyperbaric oxygen therapy compared with best practice: Anders Kjellberg, MD
  		B18: The objective effects of Hyperbaric oxygen therapy  on the chronic non-healing wounds using digital planimetry: Mor Rittblat, MD
  		B19: Severe digital frostbite treated with hyperbaric oxygen therapy: Jessica Hoge, MD
  		B20: Effectiveness of 6-week follow-up after hyperbaric oxygen treatment for carbon monoxide poisoning in identifying delayed neurological sequelae and referral to neurological services: Dallin Lindahl, MD, MS
  		B21: Oxygen concentration in and around a monoplace hyperbaric chamber after emergency decompression and defibrillation safety: Justin P. Meunier, MD
  		ORAL PRESENTATIONS
  2:00 PM	2:10 PM	B11: Association between number of hyperbaric oxygen therapy sessions and neurocognitive outcomes of acute carbon monoxide poisoning; Yong Sung Cha, MD, PhD
  2:10 PM	2:20 PM	B18: The objective effects of Hyperbaric oxygen therapy on the chronic non-healing wounds using digital planimetry; Mor Rittblat, MD
  2:20 PM	2:30 PM	A3: Sex differences in susceptibility to central nervous system oxygen toxicity: Matthew S. Makowski, MD
  4:30 PM	4:40 PM	B5: National outcomes of hyperbaric oxygen in necrotizing soft tissue infections: William Toppen, MD
  4:40 PM	4:50 PM	B6: A Randomized Trial of Preoperative Hyperbaric Oxygen (HBOT) Before Pancreaticoduodenectomy: Enrico Camporesi, MD
  4:50 PM	5:00 PM	B7: Age and diabetes increase refractive changes over time with hyperbaric oxygen: Jay Buckey, MD
  5:00 PM	5:30 PM	Posters: Session B: (B22-B41)
  		B22: U.S. multicenter randomized controlled trial of hyperbaric oxygen for COVID-19 patients with moderate to severe hypoxemia: Enoch Huang, MD, MPH&TM, FUHM
  		B23: Hyperbaric oxygen treatment + icing achieves the effects of icing and thermotherapy simultaneously in a rat acute skeletal muscle contusion model: Takashi Hoshino MD, PhD
  		B24: Dartmouth Registry Annual Report: A look at treatment of conditions outside of UHMS indications: Hideaki Leo Tanaka, MD, FACEP
  		B25: Feasibility and FDA evaluation for a Phase II Clinical Trial on efficacy of hyperbaric oxygen therapy for post COVID condition: Hideaki Leo Tanaka, MD, FACEP
  		B26: Risk factors for complications of orthopedic trauma – post hoc analysis of the HOLLT Study data: Ian Millar MBBS
  		B27: Assessing hyperbaric and undersea medicine physicians prescribing practices regarding HBO2 for non-emergent indications in patients who smoke: Kaighley Brett, MD
  		B28: A randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2): Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
  		B29: Carbon monoxide poisoning from being towed behind a boat: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
  		B30: A 19-year retrospective analysis of hyperbaric oxygen seizures : Geness Koumandakis, RRT
  		B31: Does slow and steady win the race? Consideration on optimal compression time: Samuel Hawkins, MD
  		B32: CO-oximetry in the emergency department: Jeffrey Cooper, MD
  		B33: Hyperbaric oxygen therapy for renal abscess: A case series: Kazuki Yanagida, MD
  		B34: Current trends in hyperbaric oxygen therapy use in central retinal artery occlusion management in US hyperbaric facilities: William Toppen, MD
  		B35: Neuropsychological outcomes in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury: Rosemary Ziemnik, MS
  		B36: Safety and adverse events in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2): Rosemary Ziemnik, MS
  		B37: Hyperbaric treatment improves late effects of radiation on the chest wall: Joan Chou, MD
  		B38: Successful placement and activation of artificial urethral sphincter for urinary incontinence after completing adjunctive hyperbaric oxygen therapy for radiation cystitis: Dallin Lindahl, MD, MS
  		B39: Myodesopsia after hyperbaric oxygen therapy: An unusual case report: Jiho Lee, PhD
  		B40: Hyperbaric oxygen therapy for thalamic pain syndrome: Peter Lennox MD
  		B41: HBO2 for wound in irradiated field leads to avoidance of surgery: A case report: Jayanth Adusumalli, MBBS, MPH
  SATURDAY, JUNE 17
  		ORAL PRESENTATIONS
  10:30 AM	10:40 AM	C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis; Emmanuel Dugrenot, PhD
  10:40 AM	10:50 AM	C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms: Arian Azarang, PhD
  10:50 AM	11:00 AM	C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions: Edward Ashworth, PhD
  11:00 AM	11:10 AM	C52: Elevations of inflammatory biomarkers in closed circuit SCUBA divers parallel those in DCS models: Stephen Thom, MD
  11:10 AM	11:20 AM	C53: A Novel Method for Observing Gaseous Nitrogen In Vivo and Ex Vivo Using Radioactive Nitrogen-13: Edward Ashworth, PhD
  11:20 AM	11:30 AM	C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS
  11:30 AM	12:00 PM	Posters: Session B: (B42-B51) & Session C: (C54-C62)
  		B42: Use of hyperbaric oxygenation therapy for Cyclophosphamide-Induced Hemorrhagic Cystitis.  A case report with a call for awareness and advocacy: Denise Nemeth, OMS-II, MPAS, PA-C
  		B43: CT perfusion patterns in iatrogenic cerebral arterial gas embolism: a retrospective cohort study: R.A. Fakkert, MD
  		B44: Hyperbaric oxygen therapy for cerebral radiation necrosis secondary to stereotactic radiation: A Case Series: Jeffrey Cooper, MD
  		B45: Incidence of COVID-19 history among patients with ISSNHL treated with hyperbaric oxygen therapy: Jacek Kot, MD, PhD
  		B46: Hyperbaric oxygen therapy for pyoderma gangrenosum as a new treatment strategy: HOTPANTS trial: Ellen C. Kop, MD, PhD
  		B47: A research on the application of hyperbaric oxygen  treatment for the treatment of sepsis: Xuyuan Kuang, MD, PhD
  		B48: Delayed encephalopathy of tramadol overdoses related CHANTER syndrome successfully treated with consecutive hyperbaric oxygen therapy: Naoto Jingami, MD, PhD
  		B49: Hyperbaric oxygen for long-covid condition: Joshua J. White, JD
  		B50: Why wound you heal?: Liz Eshleman, MSN, FNP-C
  		B51: E-cigarette explosion leading to oropharyngeal cancer: Jessica Coffendaffer, MSN, APRN, FNP-C
  		C54: Preliminary qualitative assessment of bubbles inside porcine lymph nodes, imaged by ultrasound after a provocative dive profile: Josh Currens, BS
  		C55: Diving into decompression sickness-resistant rat’s gene expression of genes involved in antioxidant mechanisms and mitochondrial biogenesis: Emmanuel Dugrenot, PhD
  		C56: Real-time deployment feasibility of deep learning VGE detection models for ultrasound echocardiograms: Arian Azarang, PhD
  		C57: Automated grading of venous gas emboli in Doppler ultrasound achieves human inter-rater agreement performance: A log-scale mel spectrogram-based deep learning approach: Arian Azarang, PhD
  		C58: Effects of oxygen prebreathing on tissue nitrogen content under normobaric and hyperbaric conditions: Edward Ashworth, PhD
  		C59: A PET compatible hyperbaric chamber for rodents to enable temporal and spatial monitoring of tissue nitrogen gas (nitrogen-13) in vivo: Edward Ashworth, PhD
  		C60: Pathophysiology of cutis marmorata in porcine decompression sickness: Aashay Patel, BSPH
  		C61: Stress and inflammation salivary analytes collected from standardized dives: Rhiannon Brenner
  		C62: Measuring whole-body inert gas turnover: Oscar Plogmark, MD, PhD student
  		ORAL PRESENTATIONS
  3:00 PM	3:10 PM	D65: Preliminary evidence that fourteen days of apnea and hypoxia exposures reduces circulating pro-inflammatory microparticles: Zachary Schlader, PhD
  3:10 PM	3:20 PM	D66: Analysis of chest radiographs from navy SEAL (Sea Air Land) candidates developing pulmonary symptoms while swimming: Two different patterns of what previously has been described as pulmonary: Peter Lindholm, MD, PhD
  3:20 PM	3:30 PM	D67: Arterial PCO2 during submersed prone exercise suggests attenuation of hypercapnia after respiratory muscle training: Nicholas Bartlett
  5:00 PM	5:30 PM	Posters: Session C: (C63-C64) & Session D: (D68-D83) & Session F: (F117)
  		C63: A quantitative approach to assess similarity between dives under the Bühlmann decompression algorithm constraints: Josh Currens, BS
  		C64: Analysis of gas evolution in the heart, liver and kidney of turtles presenting with decompression sickness based on ultrasonography: Katherine Eltz, BS, PhD Student
  		D68: Effects of hyperbaric exposure on perceptual-motor coordination: Nozomu Kageyama , PhD
  		D69: Nitrous oxide consistently attenuates thermogenic and thermoperceptual responses to repetitive cold stress in humans: Maaike Iris Moes, Msc
  		D70: Relative hypoxemia at depth during breath-hold diving investigated through arterial blood gas analysis and lung ultrasound: Gerardo Bosco, MD, PhD
  		D71: Evaluation and follow-up of divers after COVID-19 infection: A prospective, observational study: Charlotte Sadler, MD
  		D72: Exercise-related drops in blood oxygen saturation to diagnose marginal decompression sickness cases: Gabriela Morales, BSE
  		D73: DRACO 2023: DAN looks at increased gas consumption upon return to dive in divers with COVID-19 infection: Frauke Tillmans, PhD
  		D74: Divers treated in Townsville, Australia: Worse symptoms lead to poorer outcomes: Denise F Blake, BN, MD, FRCPC, FACEM, PGDipMedSci (DHM), Dip DHM, PhD candidate
  		D75: Cost effectiveness of urinalyses in occupational diver clearance: William Toppen, MD
  		D76: Sampler and proposed biological test for contaminated water at dive sites: Rachel M Lance, PhD
  		D77: Treatment of decompression sickness at Kawashima Orthopaedic Hospital: Masayuki Kawashima, MD
  		D78: Lack of recompression facilities for diving injuries on the Central Gulf Coast: Julio R. Garcia RN, BSN, ACHRN, WCC, FAPWCA
  		D79: Maximal fat oxidation in relation to 20 weeks of military diver training: Clara Sjöblom MSc
  		D80: Identifying low risk dive profiles in the Canadian Diving Data and Doppler Ultrasonic Data BASE: A retrospective review: Kaighley Brett, MD
  		D81: Neurocognitive performance during repetitive recreational harvesting dives: Grant Dong B.S.
  		D82: From UPTD to ESOT: Monitoring hyperoxic exposure in surface-oriented diving: Jan Risberg, MD, PhD
  		D83: State of the art review – Cardiac fitness assessment for diving in individuals with pre-existing asymptomatic coronary artery disease: Weien Chow, MRCP, M.Med
  		F116: Bedside fluorescence microangiography aids decision-making regarding hyperbaric oxygen therapy for a compromised flap: Jenny Thacker, MD, FACEP
  SUNDAY, JUNE 18
  		ORAL PRESENTATIONS
  9:00 AM	9:30 AM	E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss, CHT
  9:30 AM	9:40 AM	E92: GO/NO GO: A tool to eliminate the guesswork in determining which items may be allowed in a hyperbaric chamber: Jeff Mize RRT, CHT, UHMSADS
  9:40 AM	9:50 AM	E98: A solution for clinical hyperbaric facilities to easily standardize, track and document routine safety inspections: Checklist-based digital task manager: Tiffany Hamm BSN, RN, ACHRN, CWS, UHMSADS
  9:50 AM	10:00 AM	F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA
  2:30 PM	2:40 PM	E88: A Case to Support the Routine Monitoring and Analysis of Breathing Gases Provided to the BIBS Line from Vendor Provided K Cylinder Storage: John Sullivan, CHT
  2:40 PM	2:50 PM	E89: Barriers to 24/7 Availability and Emergent Clinical Capabilities of Hyperbaric Medicine Facilities: A Large-Scale Survey Study: John McGlynn, MD
  2:50 PM	3:00 PM	E90: Strengths and Weaknesses of Monoplace vs Multiplace Chambers for Hyperbaric Critical Care: Ian Millar, MBBS
  3:30 PM	4:00 PM	Posters: Session D: (D84-D87) & Session E: (E88-E97; E99-E101) & Session F: (F102-F103)
  		D84: Redefining work of breathing: Addressing modeling gaps in instantaneous flow models: Victoria Ribeiro Rodrigues, BS, PhD Student
  		D85: Determination of tidal volume-controlled buoyancy boundaries’ impact on diver workload efficiency: Aviad Cahana, BSc
  		D86: Crochetage pattern: An electrocardiographic warning sign for scuba divers: Sarah Crawford MD, MSc
  		D87: Development of a model to simulate underwater physiology: Tobias Cibis, PhD Candiate
  		E88: A case to support the routine monitoring and analysis of breathing gases provided to the BIBS Line from vendor-provided K cylinder storage: John Sullivan, CHT
  		E89: Barriers to 24/7 availability and emergent clinical capabilities of hyperbaric medicine facilities: A large-scale survey study: John J McGlynn, MD
  		E90: Strengths and weaknesses of monoplace vs multiplace chambers for hyperbaric critical care: Ian Millar, MBBS
  		E91: Allowing emergency decompression for inside attendant during hyperbaric oxygen therapy: Oscar Plogmark, MD, PhD student
  		E93: Laptop-style POCUS machines in the multiplace HBO2 chamber: Jenny Thacker, MD, FACEP
  		E94: The development of hyperbaric medicine in Korea since 2017: Sungmin Lee, MD, PhD
  		E95: Evaluating the function and safety of a Bluetooth™ device in the multiplace hyperbaric environment: Andrew Melnyczenko, BSHCA, CHT
  		E96: Evaluation of an elastomeric respirator for use in the multiplace hyperbaric environment: Heather Viste, BAN, RN
  		E97: Effects of airway and pressure threshold resistance on fatigue and cognition in divers: Daniel Steven Williams, BSCPE, MSEE
  		E99: Predicting tidal volume of the Zoll Z Ventilator in a hyperbaric chamber: Abigail Winn, MD
  		E100: Rapid discharge of rechargeable lithium-ion batteries at 1ATA and 3ATA: Chae Bliss BS, CHT, EMT
  		E101: How hard is it to change from lithium-ion to alkaline fuel cell in a portable device?: Tony Turner, MAICD
  		ORAL PRESENTATIONS
  4:00 PM	4:10 PM	F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series: Olayinka David Ajayi, MD, MPH
  4:10 PM	4:20 PM	F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD
  4:20 PM	4:30 PM	F104: Acute Central Retinal Artery Occlusion from Cosmetic Filler Injection: Casey Smith, MD
  4:30 PM	5:00 PM	Posters: Session F: (F104-F116; F118-F124)
  		F102: Hyperbaric oxygen therapy in the management of upper extremity frostbite injury: A case series: Olayinka David Ajayi, MD, MPH
  		F103: Fluorescence microangiography as a novel tool to identify and monitor ischemia in crush injury: Margot Samson, MD
  		F104: Acute central retinal artery occlusion from cosmetic filler injection: Casey Smith, MD
  		F105: New seizure disorders after carbon monoxide poisoning: Lindell K. Weaver, MD, FACP, FCCP, FCCM, FUHM
  		F106: Hyperbaric oxygen treatment for paracentral acute middle maculopathy: A case study: Robert Neiberger, DO
  		F107: Atypical avascular necrosis treated with hyperbaric oxygen therapy: Cheryl Hickey, MD
  		F108: Acute Traumatic Polymicrobial Pinna Perichondritis Treated with Hyperbaric Oxygen Therapy: Raymond C. Shields, MD
  		F109: Hyperbaric oxygen therapy in cases of BK virus hemorrhagic cystitis: Christopher Allen, MD
  		F110: Case report of an intractable cough due to radiation pneumonitis treated with hyperbaric oxygen: Gerald H. Markovitz, MD
  		F111: Polyarteritis nodosa treated with hyperbaric oxygen therapy: Jessica Hoge, MD
  		F112: Hyperbaric oxygen therapy for the treatment of carbon monoxide-induced delayed neurological sequelae: A case report and review of the literature: Colin Teo, MBBS
  		F113: Successful outcome from persistent brain abscess with addition of adjunctive hyperbaric oxygen therapy: Christopher Woodard, MB, BCH, BAO
  		F114: Resolution of ischemic colitis with perforation, with hyperbaric oxygen treatments: Kim Wilkinson, RN-AND
  		F115: Altitude DCS treatment options: Nathan Kwan, MAJ (Army), MD
  		F117: Massive venous gas embolism in a diver post-COVID: Jenny Thacker, MD, FACEP
  		F118: Acute cognitive impaired diver hyperbaric treatment effect: A case series: Ian Kirby, MD, CCFP, UHM
  		F119: Case report of PFO closure in an occupational diver after Type II DCS: Kaighley Brett, MD
  		F120: Immersion pulmonary edema: Not limited to a specific UBA: James E. Breuer, MD
  		F121: Alternate teatment For AGE when USN TT6 not feasible: Shane Day, DO, MPH, MS, CP
  		F122: Good result of hyperbaric oxygen therapy in a 50 year old male with chronic therapy refractair osteomyelits on the left foot, with diabetes mellitus and sensomotoric axonal polyneuropathy: Ellen C. Kop, MD, PhD
  		F123: Pneumorrhachis and pneumocephalus following epidural anesthesia for labor and delivery: A case report and systematic review: Michelle Cao, BA
  		F124: Unusual Presentation of Diplopia and Oxygen Toxicity Symptoms after 100% Oxygen Closed Circuit Rebreather Diving: A Case Report: Chiew Wenqi, MBBS

  Read more

• Christian J. Lambertsen Memorial Lecture
• Eric P. Kindwall Memorial Lecture
• Jefferson C. Davis Keynote

• CHRISTIAN J. LAMBERTSEN, MD, DSc (Hon) MEMORIAL KEYNOTE

  ---

  GUEST SPEAKER: 
  LECTURE TITLE: 
  Wednesday, June 4: 8:30 am - 10 am

  ---

  About the Lecture:  

   

  About the Speaker: 
   

  ---

  CHRISTIAN J. LAMBERTSEN, MD, DSc (Hon) MEMORIAL KEYNOTE LECTURE
  About Dr. Lambertsen:

  

  Dr. Christian J. Lambertsen received a B.S. Degree from Rutgers University in 1938 and a M.D. Degree from the University of Pennsylvania in 1943. During his medical school period, he invented and first used forms of the initial U.S. self-contained closed-circuit oxygen rebreathing apparatus, for neutral buoyancy underwater swimming and diving. As a student, he aided the early Office of Strategic Services (O.S.S.) in establishing the first cadres of U.S. military operational combat swimmers. Dr. Lambertsen became a U.S. Army medical officer on graduation from medical school in early 1943, and immediately joined the O.S.S. Maritime Unit on active duty through its period of function in World War II. He joined the University of Pennsylvania Medical Faculty in 1946, and became Professor of Pharmacology in 1952. While a faculty member he combined diving research and further underwater rebreathing equipment developments for the Army and Navy. In 1967 he served as Founding President of the Undersea Medical Society (now Undersea and Hyperbaric Medical Society.) Dr. Lambertsen is recognized by the Naval Special Warfare community as "The Father of U.S. Combat Swimming.” His hand has touched every aspect of military and commercial diving. Dr. Lambertsen’s active contributions to diving began during WWII and became even more progressive in the post-war period through the evolutions of the U.S. Navy Deep Submergence and Naval Special Warfare developmental programs. 

• ERIC P. KINDWALL, MD MEMORIAL KEYNOTE

  ---

  GUEST SPEAKER: 
  LECTURE TITLE: 
  Monday, June 2: 10:30 am - 12 pm

  ---

  About the Lecture:  

  About the Speaker: 
   

   

   

  ---

  ERIC P. KINDWALL, MD MEMORIAL KEYNOTE LECTURE
  About Dr. Kindwall:

  Dr. Kindwall is known by so many as the "Father of Hyperbaric Medicine.” Whether you knew him personally or simply by reputation, we have all benefited from his efforts, passion, wisdom, knowledge, energy and vision. Dr. Kindwall has played a great role in growing and shaping the specialty of Undersea and Hyperbaric Medicine. He was likewise instrumental in molding the UHMS into what it is today.  Dr. Kindwall began diving in 1950. He cultivated his interest in the field and during the Vietnam War served as the Assistant Director of the U.S. Navy School of Submarine Medicine. He also was the Senior Officer responsible for the Diving Medicine Program. In 1969, after leaving the Navy, Dr. Kindwall became Chief of the Department of Hyperbaric Medicine at St. Luke’s Medical Center, Milwaukee, Wis.  Shortly after the Undersea Medical Society was created in the mid-1960s, Dr. Kindwall identified the need for standardized education in the field. He created the UMS Education and Standards Committee to help elevate course content and ensure instructor competence. This committee later became our Education Committee. When the AMA initiated its Continuing Medical Education program, Dr. Kindwall persuaded the organization to recognize the UMS as a grantor of CME credits.  In 1972, Dr. Kindwall felt that the Society’s members would benefit from improved communication. He created our first newsletter and was named editor. Dr. Kindwall chose the name Pressure because clinical hyperbaric medicine was rapidly developing. Even though the UHMS had not yet incorporated "Hyperbaric” into the Society’s name, he wanted a title for the newsletter that would encompass all who worked with increased atmospheric pressure. He stated: "The Society’s goal then, as it is now, is to serve all who deal with the effects of increased barometric pressure.”  That same year, Dr. Kindwall recognized the need to have a relationship with Medicare to help provide insight on reputable clinical management. The UMS followed this lead, and a Medicare Panel was created. The recommendations were presented to the U.S. Public Health Service. The challenge was that no reliable hyperbaric medicine clinical guidelines were available that addressed appropriate applications of Hyperbaric Medicine. To remedy this deficit, the UMS Executive Committee created an Ad Hoc Committee on hyperbaric oxygen therapy. Dr. Kindwall was named Chair. The committee created the first Hyperbaric Oxygen Therapy Committee Report. Again, this text was published 10 years before the UHMS incorporated "Hyperbaric” into its name. The report was sent to HCFA and the Blues and became their source document for reimbursement. Dr. Kindwall updated the text two more times and thus was the Editor and Chair of the Committee and text for three of its 12 editions.  Dr. Kindwall later worked to expand the available information on the specialty by creating one of the first complete texts on the field. He created Hyperbaric Medicine Practice in 1994 and later updated and revised his text two more times.  The Society’s first journal, Hyperbaric Oxygen Review, has also has been influenced by Dr. Kindwall. His love for research and education was clear: He became the initial editor, creating a journal that at first consisted of review articles and one original contribution. Over the years,it has grown to one full of original research.  Dr. Kindwall’s presence is felt in so many of the UHMS’ activities and initiatives. Much of what we all take for granted – what is just "there” and "available” – has his touch and influence. Some of us have been blessed to have had a closer impact by Dr. Kindwall’s life, but I think that I can easily say that each of us has been influenced in some way.

• Jefferson C. Davis Memorial Keynote

  ---

  GUEST SPEAKER: 
  LECTURE TITLE: 
  Thursday, June 5: 10 am - 11 am

  ---

  About the Lecture:  
  
  
  

  About the Speaker:

  
   

  ---

  JEFFERSON C. DAVIS, MD KEYNOTE LECTURE
  About Dr. Davis:

   Dr. Jefferson C. Davis devoted his entire adult life serving the diving, aerospace and hyperbaric communities.  Through his clinical practice, educational activities, and publications, he inspired several generations of clinicians to provide quality medical service for divers, aviators, and hyperbaric medicine & wound care patients.  

  Dr. Davis was born December 7, 1932, and raised in Neosho, Missouri.  After receiving his MD at the University of Missouri in 1958, he joined the US Air Force Medical Corps to become a flight surgeon.  He received his MPH from the University of California at Berkeley and was board certified in Aerospace Medicine.  He studied diving medicine at the US Navy Experimental Diving Unit in Washington DC.  In 1965, Dr. Davis and his colleagues created the first US Air Force course in Hyperbaric Medicine.  He founded “LEOFAST,” the US Air Force predecessor of Divers Alert Network.  In 1974 he founded and became the first Director of the USAF Hyperbaric Medicine Center at Brooks Air Force Base Texas, which now bears his name.  He created the Davis Protocol in the application of Hyperbaric Medicine for wound healing enhancement.  He became Medical Director for Medical Seminars’ Medicine of Diving Program in which physicians from all medical specialties could learn to treat injured divers and to serve as consults to their local diving communities.  In 1979, after 20 years of service Dr. Davis retired from the US Air Force as a Chief Flight Surgeon in the grade of Colonel.  Dr. Davis became founding member and president of International ATMO, Inc. the first know contract provider of wound care and hyperbaric medicine services.   He set up a successful practice at two San Antonio hospitals.

  His compassion for his patient’s well-being was legendary and he contributed much to the diving, aerospace and hyperbaric medicine communities.

-In order to receive continuing education credits you must complete and submit an evaluation-

Accreditation Statement: 
The Undersea and Hyperbaric Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statements:

• Physician CME: The Undersea and Hyperbaric Medical Society designates this live activity for a maximum of TBD AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Nursing/RRT Contact Hours: This live activity is approved for TBD CE hours provided by Florida Board of Registered Nursing/RRT Provider #50-10881. License types: RN, LPN, CNS, ARNP, CNA, CRT, RRT, RCP Provided through the Florida State Board of Nursing and the CE credits are reciprocal and approved for nurses within all states. Receiving credit for Florida providers is simple, attend the course and our staff will upload your credits directly to the Florida State database. For out of state credit, we provide this letter for you to file with the respective nursing board.
• NBDHMT: This live activity is approved for TBD* Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, P.O. Box 758, Pelion, South Carolina 29123.  *Up to TBD Cat A credits for the in-person/live stream meeting and up to TBD Cat A credits for reviewing poster review/quiz online at your leisure.  Not to exceed 20 total maximum Cat A credit hours.  CLICK HERE for approved lectures & posters.
  • NBDHMT Accreditation Statement: For CHT recertification purposes, the NBDHMT requires a minimum of nine of the minimum 12 required Category A credits relate directly to any combination of hyperbaric operations, related technical aspects and chamber safety.

Full Disclosure Statement: Individuals in control of content participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with ineligible companies. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.            

Disclosure:

The following individuals have disclosed a relevant financial relationship with ineligible companies. Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education:

A financial relationship, in any amount, exists between the person in control of content and an ineligible company and;

1. The content of the education is related to the products of an ineligible company with whom the person has a financial relationship and;
2. The financial relationship existed during the past 24 months.
3. All of the relevant financial relationships listed for these individuals have been mitigated.

• None of the individuals in control of content (planners/faculty/reviewers/authors) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
• The following commercial support was received for this activity.
  • Fink Engineering, unrestricted educational grant $6500
  • Hyperbaric Modular Systems, Inc,. financial support: $2500

Disclaimer: The information provided at this CME activity is for Continuing Medical Education purposes only. The lecture content, statements or opinions expressed however, do not necessarily represent those of the Undersea and Hyperbaric Medical Society.

Note for ABMS Board Certified Physicians: Some ABMS boards will accept accredited CME towards their MOC requirements. As an accredited provider, the UHMS can now register educational activities as CME for MOC (Part II) for ACCME collaborating boards. Please review the learner instructions and submit the necessary requirements for your credit to be reported within 30 days of course closing. Learner CME credit must be reported no later than December 1st of the reporting year. If your board is not collaborating yet with ACCME to report CME for MOC, please continue to submit your credits to your certifying board directly.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to: 

• 20MOC points in the American Board of Anesthesiology (ABA) Maintenance of Certification(MOC) program; and
• 20MOC points in the American Board of Internal Medicine's (ABIM) Maintenance ofCertification (MOC) program; and 
• 20MOC points in the American Board of American Board of Otolaryngology – Head and Neck Surgery (ABOHNS) Continuing Certification Program (CCP); and
• 20MOC points in the American Board of Orthopaedic Surgery (ABOS) Maintenance of Certification (MOC) program; and
• 20MOC points in the American Board of Pathology (ABPath) Continuing Certification Program (CCP); and
• 20MOC points in the American Board of Surgery (ABS) Maintenance of Certification (MOC) program; and
• 20MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification(MOC) program; and 
• 20MOC points in the American Board of Thoracic Surgery (ABTS) Maintenance of Certification(MOC) program.

CME For MOC Program Guide Designation Statements for ABMS Boards

Required instructions to learners on how to obtain CME for MOC

CME For MOC points are earned through completing a comprehensive evaluation component that assesses individual learner competence, performance, and/or the impact on patient outcomes. Some boards require evaluation feedback that will include a summary of what was discussed and the best next steps for the learner. The evaluation feedback will be provided to you upon submitting the evaluation form.

As an accredited ACCME provider, the UHMS is now responsible to submit physician learner CME credits into the ACCME PARS system. However, it is the physician’s responsibility to submit the necessary information required to match with the ACCME PARS system. It is also the physicians responsibility to check with their respective board(s) to see that the credits were applied accordingly.

• American Board of Anesthesiology (ABA)
  “This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology^TM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.”
• American Board of Internal Medicine (ABIM)***
  “Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to [credits approved] MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”
• American Board of Otolaryngology – Head and Neck Surgery (ABOHNS) ***
  “Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.”
• American Board of Orthopaedic Surgery (ABOS) ***
  “Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Orthopaedic Surgery’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit."
• American Board of Pathology (ABPath)
  This activity has been registered to offer [credits approved] AMA PRA Category 1 Credits^TM towards the American Board of Pathology’s Continuing Certification program Lifelong Learning credits.
• American Board of Pediatrics (ABP) ***
  “Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to [credits approved] MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.”
• American Board of Surgery (ABS) ***
  “Successful completion of this CME activity [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment] requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit."
• American Board of Thoracic Surgery (ABTS) ***
  “Successful completion of this CME activity [which includes participation in the evaluation component,] enables the learner to earn credit toward the CME [and Self-Assessment] of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit."

***Will require evaluation feedback

SUBJECT TO CHANGE
posted 6/5/24
Please contact lisa@uhms.org to schedule.
<BACK>

• NBDHMT:This live activity is approved for a maximum of 20* Category A credit hours by National Board of Diving and Hyperbaric Medical Technology, P.O. Box 758, Pelion, South Carolina 29123.  *Up to 15 Cat A credits for the in-person/live stream meeting and up to 5 Cat A credits for reviewing posters/quiz online at your leisure.  Not to exceed 20 total maximum Cat A credit hours.  
  • NBDHMT Accreditation Statement: For CHT recertification purposes, the NBDHMT requires a minimum of nine of the minimum 12 required Category A credits relate directly to any combination of hyperbaric operations, related technical aspects and chamber safety.

In-Person / Live Stream Credits (evaluation must be completed): up to 15 Cat A Credit hours.

Up to 5 Cat A credits for reviewing approved posters and submitting a quiz online at your leisure. Below is the list of the approved posters.  Links will be provided after attendance.

• Friday, June 16: 11:30 am - 12:00 pm
  B 10: Retrospective assessment of the “Duke Mods”, An approach to reducing hyperbaric tender decompression sickness risk for multiplace chamber operations
  Presenting Author: M. Claire Ellis
• Friday, June 16: 11:30 am - 12:00 pm
  B 13: Hyperbaric oxygen therapy regimens, treated conditions, and adverse effect profile: A UHMS survey study
  Presenting Author: Matteo Laspro, BA
• Friday, June 16: 11:30 am - 12:00 pm
  B 15: Early hyperbaric oxygen therapy is associated with favorable outcome in iatrogenic cerebral arterial gas embolism: Individual patient data meta-analysis of observational studies
  Presenting Author: Robert P. Weenink, CAPT (Navy), MD, PhD
• Friday, June 16: 11:30 am - 12:00 pm
  B 21: Oxygen concentration in and around a monoplace hyperbaric chamber after emergency decompression and defibrillation safety
  Presenting Author: Justin P. Meunier, MD
• Friday, June 16: 5:00 pm - 5:30 pm
  B 27: Assessing hyperbaric and undersea medicine physicians prescribing practices regarding HBO2 for non-emergent indications in patients who smoke
  Presenting Author: Kaighley Brett, MD
• Friday, June 16: 5:00 pm - 5:30 pm
  B 30: A 19-year retrospective analysis of hyperbaric oxygen seizures
  Presenting Author: Geness Koumandakis, RRT
• Friday, June 16: 5:00 pm - 5:30 pm
  B 31: Does slow and steady win the race? Consideration on optimal compression time
  Presenting Author: Samuel Hawkins, MD
• Friday, June 16: 5:00 pm - 5:30 pm
  B 36: Safety and adverse events in a randomized, double-blind trial of hyperbaric oxygen for persistent symptoms after brain injury (HYBOBI-2)
  Presenting Author: Rosemary Ziemnik, MS
• Saturday, June 17: 5:00 pm - 5:30 pm
  B 39: Myodesopsia after hyperbaric oxygen therapy: An unusual case report
  Presenting Author: Sangwon Ko, MD 
• Saturday, June 17: 11:30 am - 12:00 pm
  B 43: CT perfusion patterns in iatrogenic cerebral arterial gas embolism: a retrospective cohort study
  Presenting Author: R.A. Fakkert, MD
• Saturday, June 17: 11:30 am - 12:00 pm
  C 57: Automated grading of venous gas emboli in Doppler ultrasound achieves human inter-rater agreement performance: A log-scale mel spectrogram-based deep learning approach
  Presenting Author: Arian Azarang, PhD
• Saturday, June 17: 11:30 am - 12:00 pm
  C 59: A PET compatible hyperbaric chamber for rodents to enable temporal and spatial monitoring of tissue nitrogen gas (nitrogen-13) in vivo
  Presenting Author: Edward Ashworth, PhD
• Saturday, June 17: 11:30 am - 12:00 pm
  C 60: Pathophysiology of cutis marmorata in porcine decompression sickness
  Presenting Author: Aashay Patel, BSPH
• Saturday, June 17: 11:30 am - 12:00 pm
  C 61: Stress and inflammation salivary analytes collected from standardized dives
  Presenting Author: Rhiannon Brenner
• Saturday, June 17: 11:30 am - 12:00 pm
  C 62: Measuring whole-body inert gas turnover
  Presenting Author: Oscar Plogmark, MD, PhD student
• Saturday, June 17: 5:00 pm - 5:30 pm
  C 63: A quantitative approach to assess similarity between dives under the Bühlmann decompression algorithm constraints
  Presenting Author: Josh Currens, BS
• Saturday, June 17: 5:00 pm - 5:30 pm
  D 72: Exercise-related drops in blood oxygen saturation to diagnose marginal decompression sickness cases
  Presenting Author: Gabriela Morales, BSE
• Saturday, June 17: 5:00 pm - 5:30 pm
  D 74: Divers treated in Townsville, Australia: Worse symptoms lead to poorer outcomes
  Presenting Author: Dr Denise F Blake, BN, MD, FRCPC, FACEM, PGDipMedSci (DHM), Dip DHM, PhD candidate
• Saturday, June 17: 5:00 pm - 5:30 pm
  D 77: Treatment of decompression sickness at Kawashima Orthopaedic Hospital
  Presenting Author: Masayuki Kawashima, MD
• Saturday, June 17: 5:00 pm - 5:30 pm
  D 78: Lack of recompression facilities for diving injuries on the Central Gulf Coast
  Presenting Author: Julio R. Garcia RN, BSN, ACHRN, WCC, FAPWCA
• Saturday, June 17: 5:00 pm - 5:30 pm
  D 82: From UPTD to ESOT: Monitoring hyperoxic exposure in surface-oriented diving
  Presenting Author: Jan Risberg, MD, PhD
• Saturday, June 17: 5:00 pm - 5:30 pm
  D 83: State of the art review – Cardiac fitness assessment for diving in individuals with pre-existing asymptomatic coronary artery disease
  Presenting Author: Weien Chow, MRCP, M.Med
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 88: A case to support the routine monitoring and analysis of breathing gases provided to the BIBS Line from vendor-provided K cylinder storage
  Presenting Author: John Sullivan, CHT
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 89: Barriers to 24/7 availability and emergent clinical capabilities of hyperbaric medicine facilities: A large-scale survey study
  Presenting Author: John J McGlynn, MD
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 90: Strengths and weaknesses of monoplace vs multiplace chambers for hyperbaric critical care
  Presenting Author: Ian Millar, MBBS
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 91: Allowing emergency decompression for inside attendant during hyperbaric oxygen therapy
  Presenting Author: Oscar Plogmark, MD, PhD student
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 93: Laptop-style POCUS machines in the multiplace HBO2 chamber
  Presenting Author: Jenny Thacker, MD, FACEP
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 95: Evaluating the function and safety of a Bluetooth™ device in the multiplace hyperbaric environment
  Presenting Author: Andrew Melnyczenko, BSHCA, CHT
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 96: Evaluation of an elastomeric respirator for use in the multiplace hyperbaric environment
  Presenting Author: Heather Viste, BAN, RN
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 99: Predicting tidal volume of the Zoll Z Ventilator in a hyperbaric chamber
  Presenting Author: Abigail Winn, MD
• Sunday, June 18: 3:00 pm - 3:30 pm
  E 101: How hard is it to change from lithium-ion to alkaline fuel cell in a portable device?
  Presenting Author: Tony Turner, MAICD
• Sunday, June 18: 4:30 pm - 5:00 pm
  F 115: Altitude DCS treatment options
  Presenting Author: Nathan Kwan, MAJ (Army), MD
• Sunday, June 18: 4:30 pm - 5:00 pm
  F 118: Acute cognitive impaired diver hyperbaric treatment effect: A case series
  Presenting Author: Ian Kirby, MD, CCFP, UHM
• Sunday, June 18: 4:30 pm - 5:00 pm
  F 119: Case report of PFO closure in an occupational diver after Type II DCS
  Presenting Author: Kaighley Brett, MD
• Sunday, June 18: 4:30 pm - 5:00 pm
  F 121: Alternate teatment For AGE when USN TT6 not feasible
  Presenting Author: Shane Day, DO, MPH, MS, CP

CATEGORY A SCHEDULE